mRNA |
cimetidine |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
0.02 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.082 |
0.02 |
mRNA |
apicidin |
CTRPv2 |
pan-cancer |
AAC |
-0.078 |
0.02 |
mRNA |
ABT-888 |
CTRPv2 |
pan-cancer |
AAC |
0.092 |
0.02 |
mRNA |
Nutlin-3a (-) |
GDSC1000 |
pan-cancer |
AAC |
-0.082 |
0.02 |
mRNA |
docetaxel:tanespimycin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.08 |
0.02 |
mRNA |
Irinotecan |
CCLE |
pan-cancer |
AAC |
-0.13 |
0.02 |
mRNA |
BCL-LZH-4 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.02 |
mRNA |
Camptothecin |
GDSC1000 |
pan-cancer |
AAC |
-0.078 |
0.02 |
mRNA |
TGX221 |
CTRPv2 |
pan-cancer |
AAC |
0.089 |
0.02 |